| 1 |
吴开春，梁洁，冉志华，等．炎症性肠病诊断与治疗的共识意见(2018年·北京)[J]．中国实用内科杂志，2018，38(9)：796-813.
|
| 2 |
Gajendran M，Loganathan P，Jimenez G，et al.A comprehensive review and update on ulcerative colitis [J]．Disease-a-Month，2019，65(12)：1557-8194.
|
| 3 |
Pantavou K，Yiallourou A I，Piovani D，et al.Efficacy and safety of biologic agents and tofacitinib in moderate-to-severe ulcerative colitis：A systematic overview of meta-analyses [J]．United European Gastroenterology Journal，2019，7(10)：2050-6414.
|
| 4 |
江学良．非清髓脐带血干细胞治疗激素抵抗型溃疡性结肠炎临床研究[J]．中华消化内镜杂志，2010，27(8)：423-426.
|
| 5 |
于晓雯，曹震，张健，等．细胞治疗产品开发流程及管理对策[J]．中国医药生物技术，2018，13(3)：281-285.
|
| 6 |
杨立新，钱家鸣．造血干细胞移植与炎症性肠病[J]．中华内科杂志，2005，40(1)：65-67.
|
| 7 |
Drakos PE，Nagler A．Case of Crohn′s disease in bone marrow transplantation [J]．Am J Hematol，1993，43(2)：157-158.
|
| 8 |
Ditschkowski M，Einsele H，Schwerdtfeger R，et al.Improvement of inflammatory bowel disease after allogeneic stem-cell transplantation [J]．Transplantation，2003，75(10)：1745-1747.
|
| 9 |
Jauregui-Amezaga A，Rovira M，Marin P，et al.Improving safety of autologous haematopoietic stem cell transplantation in patients with Crohn′s disease [J]．Gut，2016，65(9)：1456-1462.
|
| 10 |
Lindsay JO，Allez M，Clark M，et al.Autologous stem-cell transplantation in treatment-refractory Crohn′s disease：an analysis of pooled data from the ASTIC trial [J]．Lancet Gastroenterol Hepatol，2017，2(6)：399-406.
|
| 11 |
Pockley AG，Lindasy JO，Foulds GA，et al.Immune Reconstitution After Autologous Hematopoietic Stem Cell Transplantation in Crohn′s Disease：Current Status and Future Directions.A Review on Behalf of the EBMT Autoimmune Diseases Working Party and the Autologous Stem Cell Transplantation In Refractory CD-Low Intensity Therapy Evaluation Study Investigators [J]．Front Immunol，2018，9：646.
|
| 12 |
López-Garcia A，Rovira M，Jauregui-Amezaga A，et al.Autologous Haematopoietic Stem Cell Transplantation for Refractory Crohn′s Disease：Efficacy in a Single-Centre Cohort [J]．J Crohns Colitis，2017，11(10)：1161-1168.
|
| 13 |
江学良．干细胞治疗顽固性溃疡性结肠炎探讨[J]．中国处方药，2010(2)：41-43，72.
|
| 14 |
江学良，崔慧斐．顽固性溃疡性结肠炎治疗的新方法[J]．世界华人消化杂志，2011，19(18)：1871-1873.
|
| 15 |
Chen L，Gao Y，Zhang Z，et al.Umbilical cord blood mononuclear cell therapy induces clinical remission of steroid-dependent or-resistant ulcerative colitis patients [J]．Oncotarget，2018，9(19)：15027-15035.
|
| 16 |
Dhere T，Copland I，Garcia M，et al.The safety of autologous and metabolically fit bone marrow mesenchymal stromal cells in medically refractory Crohn′s disease-a phase 1 trial with three doses [J]．Alimentary Pharmacology & Therapeutics，2016，44(5)：471-481.
|
| 17 |
Portilla FDL，Alba F，Garcia-Olmo D，et al.Expanded allogeneic adipose-derived stem cells(eASCs)for the treatment of complex perianal fistula in Crohn′s disease：results from a multicenter phase I/IIa clinical trial [J]．International Journal of Colorectal Disease，2013，28(3)：313-323.
|
| 18 |
Forbes GM，Sturm MJ，Leong RW，et al.A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn′s disease refractory to biologic therapy [J]．Clin Gastroenterol Hepatol，2014，12(1)：64-71.
|
| 19 |
Dietz AB，Dozois EJ，Fletcher JG，et al.Autologous Mesenchymal Stem Cells，Applied in a Bioabsorbable Matrix，for Treatment of Perianal Fistulas in Patients With Crohn′s Disease[J]．Gastroenterology，2017，153(1)：59-62.
|
| 20 |
Lightner AL，Dozois EJ，Dietz AB，et al.Matrix-Delivered Autologous Mesenchymal Stem Cell Therapy for Refractory Rectovaginal Crohn′s Fistulas [J]．Inflamm Bowel Dis，2020，26(5)：670-677.
|
| 21 |
Hu J，Zhao G，Zhang L，et al.Safety and therapeutic effect of mesenchymal stem cell infusion on moderate to severe ulcerative colitis [J]．Exp Ther Med，2016，12(5)：2983-2989.
|
| 22 |
Molendijk I，Bonsing BA，Roelofs H，et al.Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells Promote Healing of Refractory Perianal Fistulas in Patients With Crohn′s Disease[J]．Gastroenterology，2015，149(4)：918-927.
|
| 23 |
Barnhoorn MC，Van Halteren AGS，Van Pel M，et al.Lymphoproliferative Disease in the Rectum 4 Years After Local Mesenchymal Stromal Cell Therapy for Refractory Perianal Crohn′s Fistulas：A Case Report[J]．J Crohns Colitis，2019，13(6)：807-811.
|
| 24 |
Barnhoorn MC，Wasser M，Roelofs H，et al.Long-term Evaluation of Allogeneic Bone Marrow-derived Mesenchymal Stromal Cell Therapy for Crohn′s Disease Perianal Fistulas [J]．J Crohns Colitis，2020，14(1)：64-70.
|
| 25 |
Garcia-Olmo D，Garcia-Arranz M，Herreros D，et al.A phase I clinical trial of the treatment of Crohn′s fistula by adipose mesenchymal stem cell transplantation[J]．Dis Colon Rectum，2005，48(7)：1416-1423.
|
| 26 |
Cho YB，Park KJ，Yoon SN，et al.Long-term results of adipose-derived stem cell therapy for the treatment of Crohn′s fistula [J]．Stem Cells Transl Med，2015，4(5)：532-537.
|
| 27 |
Panes J，Garcia-Olmo D，Van Assche G，et al.Expanded allogeneic adipose-derived mesenchymal stem cells(Cx601)for complex perianal fistulas in Crohn′s disease：a phase 3 randomised，double-blind controlled trial [J]．Lancet，2016，388(10051)：1281-1290.
|
| 28 |
Panes J，Garcia-Olmo D，Van Assche G，et al.Long-term Efficacy and Safety of Stem Cell Therapy(Cx601)for Complex Perianal Fistulas in Patients With Crohn′s Disease [J]．Gastroenterology，2018，154(5)：1334-1342.
|
| 29 |
Zhou C，Li M，Zhang Y，et al.Autologous adipose-derived stem cells for the treatment of Crohn′s fistula-in-ano：an open-label，controlled trial [J]．Stem Cell Res Ther，2020，11(1)：124.
|